Skip to main content
DongKook Life Science Co., Ltd. logo

DongKook Life Science Co., Ltd. — Investor Relations & Filings

Ticker · 303810 ISIN · KR7303810006 KO Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2025-02-24 Director's Dealing
Country KR South Korea
Listing KO 303810

About DongKook Life Science Co., Ltd.

http://www.dkls.co.kr/eng/

DongKook Life Science Co., Ltd. is a specialized pharmaceutical company focused on diagnostic medicine and medical devices. The company develops, manufactures, and supplies a range of products with a core specialization in contrast media for medical imaging modalities such as X-ray and magnetic resonance imaging (MRI). In addition to its diagnostic pharmaceuticals, the company is involved in developing AI-powered medical technology. With a strong emphasis on research and development, DongKook Life Science focuses on technical innovation and the creation of new products, having successfully localized key diagnostic medicines for the market. The company serves a global customer base across numerous countries.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing' report) where executives or major shareholders disclose changes in their shareholdings. Based on the provided filing categories, this aligns perfectly with 'Director's Dealing' (DIRS).
2025-02-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is specifically used to disclose insider shareholdings and transactions by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2025-02-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by insiders or major shareholders. This falls under the category of 'Director's Dealing' (DIRS) as it details the acquisition and disposal of shares by a major shareholder (Life Value-up Private Equity Fund) in the company Dongkook Life Science.
2025-02-24 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership of '라이프밸류업사모투자합자회사' in '동국생명과학'. Since this document reports a change in significant share ownership (crossing thresholds) and is a formal regulatory disclosure, it falls under the 'Major Shareholding Notification' category.
2025-02-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership of DongKook Pharmaceutical and its special related parties in DongKook Life Science. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership stakes and changes therein.
2025-02-21 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in shareholdings by insiders or major shareholders, which corresponds to the 'Director's Dealing' category in the provided taxonomy.
2025-02-21 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.